JP2011528903A5 - - Google Patents

Download PDF

Info

Publication number
JP2011528903A5
JP2011528903A5 JP2011520029A JP2011520029A JP2011528903A5 JP 2011528903 A5 JP2011528903 A5 JP 2011528903A5 JP 2011520029 A JP2011520029 A JP 2011520029A JP 2011520029 A JP2011520029 A JP 2011520029A JP 2011528903 A5 JP2011528903 A5 JP 2011528903A5
Authority
JP
Japan
Prior art keywords
tls
fus
als
detecting
genetic markers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011520029A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011528903A (ja
JP5643200B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/004205 external-priority patent/WO2010011283A2/en
Publication of JP2011528903A publication Critical patent/JP2011528903A/ja
Publication of JP2011528903A5 publication Critical patent/JP2011528903A5/ja
Application granted granted Critical
Publication of JP5643200B2 publication Critical patent/JP5643200B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011520029A 2008-07-22 2009-07-21 筋萎縮性側索硬化症および関連する運動ニューロン疾患の診断、処置および予防のための、fus/tlsベースの化合物および方法 Active JP5643200B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13568908P 2008-07-22 2008-07-22
US61/135,689 2008-07-22
PCT/US2009/004205 WO2010011283A2 (en) 2008-07-22 2009-07-21 Fus/tls-based compounds and methods for diagnosis, treatment and prevention of amyotrophic lateral sclerosis and related motor neuron diseases

Publications (3)

Publication Number Publication Date
JP2011528903A JP2011528903A (ja) 2011-12-01
JP2011528903A5 true JP2011528903A5 (enExample) 2012-09-06
JP5643200B2 JP5643200B2 (ja) 2014-12-17

Family

ID=41570769

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011520029A Active JP5643200B2 (ja) 2008-07-22 2009-07-21 筋萎縮性側索硬化症および関連する運動ニューロン疾患の診断、処置および予防のための、fus/tlsベースの化合物および方法

Country Status (4)

Country Link
US (3) US9150860B2 (enExample)
JP (1) JP5643200B2 (enExample)
CA (1) CA2731643C (enExample)
WO (1) WO2010011283A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010011283A2 (en) 2008-07-22 2010-01-28 The General Hospital Corporation Fus/tls-based compounds and methods for diagnosis, treatment and prevention of amyotrophic lateral sclerosis and related motor neuron diseases
JP6342627B2 (ja) * 2013-08-02 2018-06-13 国立大学法人 東京大学 筋萎縮性側索硬化症の新規病因遺伝子
EP3573637A4 (en) * 2017-01-27 2020-11-11 Vanderbilt University INHIBITORS OF NUCLEAR TRANSLOCATION OF FUS PROTEIN ENABLING THE PREVENTION OF FIBROSIS
EP3601541A4 (en) * 2017-03-22 2020-10-28 Tsinghua University MUTANT FUS MODEL FOR ALS
WO2018170796A1 (en) * 2017-03-22 2018-09-27 Tsinghua University Trim72 as potential therapeutic target for als through ubiquitinating mutant fus protein
JP7295584B2 (ja) * 2018-11-09 2023-06-21 スンチョニャン ユニヴァーシティ インダストリー アカデミー コーペレーション ファウンデーション 神経系退行性疾患診断用マーカーおよび治療用組成物
EP3892283A1 (en) * 2020-04-09 2021-10-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Nucleic acids encoding human fus protein and use in the treatment of amyotrophic lateral sclerosis (als)
JP7541100B2 (ja) * 2020-09-09 2024-08-27 大原薬品工業株式会社 siRNAおよびその用途
WO2022082199A1 (en) * 2020-10-16 2022-04-21 Pluripotent Diagnostics Corp. Method for detecting amyotrophic lateral sclerosis
EP4412708A4 (en) * 2021-10-05 2025-12-03 The J David Gladstone Inst A Testamentary Trust Established Under The Will Of J David Gladstone SPECIFIC EDITION OF AN ALLELE TO TREAT FUS-INDUCED NEURODEGENERATION
US20250101420A1 (en) * 2022-03-08 2025-03-27 Ohara Pharmaceutical Co., Ltd. MODIFIED siRNA FOR SELECTIVELY INHIBITING EXPRESSION OF MUTANT FUS
CN116042619B (zh) * 2022-12-19 2023-09-08 神济昌华(北京)生物科技有限公司 用于构建人源FUS基因敲入的ALS果蝇模型的gRNA组合及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582908B2 (en) * 1990-12-06 2003-06-24 Affymetrix, Inc. Oligonucleotides
US5843641A (en) 1993-02-26 1998-12-01 Massachusetts Institute Of Technology Methods for the daignosis, of familial amyotrophic lateral sclerosis
JP2002306179A (ja) 2001-04-16 2002-10-22 Japan Science & Technology Corp Als2cr6遺伝子と、2型筋萎縮性側索硬化症の診断方法
AU2003302264A1 (en) * 2002-12-20 2004-09-09 Biotrove, Inc. Assay apparatus and method using microfluidic arrays
CA2528162A1 (en) 2003-06-04 2004-12-16 The Government Of The United States As Represented By The Secretary Of T He Department Of Health And Human Services, Centers For Disease Control Pni microarray and uses
US20070009899A1 (en) * 2003-10-02 2007-01-11 Mounts William M Nucleic acid arrays for detecting gene expression in animal models of inflammatory diseases
US20090253583A1 (en) * 2004-09-27 2009-10-08 Med Biogene Inc. Hematological Cancer Profiling System
US20070202537A1 (en) 2005-12-05 2007-08-30 Prosetta Corporation Biomarkers for als
NZ578914A (en) 2007-01-08 2012-11-30 Andhoscience Corp Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and uses thereof
WO2010011283A2 (en) 2008-07-22 2010-01-28 The General Hospital Corporation Fus/tls-based compounds and methods for diagnosis, treatment and prevention of amyotrophic lateral sclerosis and related motor neuron diseases

Similar Documents

Publication Publication Date Title
JP2011528903A5 (enExample)
JP2014533949A5 (enExample)
Martino et al. Longitudinal, genome-scale analysis of DNA methylation in twins from birth to 18 months of age reveals rapid epigenetic change in early life and pair-specific effects of discordance
JP5683964B2 (ja) Snpアレイを用いた染色体、遺伝子または特定ヌクレオチド配列のコピー数測定方法
JP2010075182A5 (enExample)
JP2012503985A5 (enExample)
JP6622731B2 (ja) 歯周病の重症度および進行を決定するための改良された方法およびキット
JP2008546403A5 (enExample)
JP2009526524A5 (enExample)
JP2009509508A5 (enExample)
JP2008526249A5 (enExample)
JP2011097925A5 (enExample)
JP2010528590A5 (enExample)
JP2010534069A5 (enExample)
RU2014123511A (ru) Способы лечения, диагностики и мониторинга болезни альцгеймера
JP2010520745A5 (enExample)
JP2009523005A5 (enExample)
ES2744592T3 (es) Marcadores mitocondriales de enfermedades neurodegenerativas
CA2735129A1 (en) Syngap1 dysfunctions and uses thereof in diagnostic and therapeutic applications for mental retardation
CN102808030B (zh) 单核苷多态性rs3888188在检测结核病易感性中的应用
JP2011097926A5 (enExample)
JP2013074888A (ja) IL28B(rs8099917)とITPA(rs1127354)の変異を検出する方法
US20130157873A1 (en) Methods of assessing a risk of developing necrotizing meningoencephalitis
CN103003428B (zh) 一种用于预测对于抗癌靶向治疗制剂的敏感性的snp
TWI661050B (zh) 評估子宮頸癌風險之方法